Moderna says its Covid-19 vaccine shows 93% effectiveness through at least six months. It expects to submit for FDA full approval this month.
Moderna’s Covid-19 vaccine shows 93% efficacy through six months, and the company expects to complete its application for full US Food and Drug Administration approval this month, it said in a news release Thursday.
“In final analysis of Phase 3 COVE study data, the Moderna COVID-19 Vaccine showed 93% efficacy, with the efficacy remaining durable through six months after administration of the second dose,” the news release said. “Moderna has initiated the rolling submission process for a Biologics License Application for our vaccine in the U.S. and expects to complete its submission in August.”The data reflecting 93% efficacy reflected participants who had been fully vaccinated by Nov. 2020 and evaluated again four to six months later, prior to the current surge of Delta related cases in the US.
“I am proud of the progress our teams at Moderna have made in the past quarter in advancing our development pipeline while addressing a global pandemic and quickly establishing global manufacturing and commercial organizations,” Moderna CEO Stéphane Bancel said in the news release. “We now have mRNA candidates in clinical trials across five therapeutic areas including infectious diseases, cardiovascular, oncology, rare disease and autoimmune disorders.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
FDA aims for full approval of Pfizer COVID-19 vaccine by Labor Day: reportThe U.S. Food and Drug Administration is aiming to grant full approval of the Pfizer-BioNTech coronavirus vaccine by Labor Day or sooner, according to a new...
Leer más »
Opinion | The FDA Finally Gets Moving on PfizerFrom WSJopinion: If the “emergency” label is holding people back from vaccinations, then there is no higher public-health priority than reassuring Americans that evidence shows the vaccine is safe and saving lives, writes The Editorial Board
Leer más »
FDA Wants To Fully Approve Pfizer Vaccine By Early September: ReportFull approval is expected to give a boost to vaccine mandates around the country.
Leer más »
FDA Accelerates Timeline for Final Approval of Pfizer VaccineThe regulatory agency reportedly has an unofficial deadline of Labor Day or sooner, clearing potential legal hurdles for some vaccine mandates.
Leer más »
FDA Wants To Fully Approve Pfizer Vaccine By Early September: ReportFull approval is expected to give a boost to vaccine mandates around the country.
Leer más »